Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PTC THERAPEUTICS, INC. Director's Dealing 2013

Jun 28, 2013

31046_dirs_2013-06-28_09ac03f4-cbf1-48ca-88fa-c78da0423595.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2013-06-25

Reporting Person: HBM Healthcare Investments (Cayman) Ltd. (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-06-25 Common Stock C 280178 Acquired 280178 Direct
2013-06-25 Common Stock C 1561317 Acquired 1841495 Direct
2013-06-25 Common Stock P 666676 $15.00 Acquired 2508171 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2013-06-25 Series Four Senior Preferred Stock $0 C 280178 Disposed Common Stock (280178) Direct
2013-06-25 Series Five Junior Preferred Stock $0 C 1561317 Disposed Common Stock (1561317) Direct

Footnotes

F1: Each share of issuer's Series Four Senior Preferred Stock converted into 1 share of the issuer's Common Stock on June 25, 2013 pursuant to an election by the holders of a majority of the shares of the issuer's preferred stock in connection with the closing of the issuer's firm commitment underwritten public offerng pursuant to a registration statement on Form S-1 under the Securities Act of 1933, as amended (the "IPO") and had no expiration date.

F2: Each share of issuer's Series Five Junior Preferred Stock converted into 1 share of the issuer's Common Stock on June 25, 2013 pursuant to an election by the holders of a majority of the shares of the issuer's preferred stock in connection with the closing of the issuer's IPO and had no expiration date.